The effect of combined CJZ3, a lomerizine derivative, with verapamil on P-glycoprotein efflux function in vitro

Biansheng Ji,Yan L. Ren,Ling He
DOI: https://doi.org/10.1002/ddr.20430
2011-01-01
Drug Development Research
Abstract:In the effort to inhibit P-glycoprotein (P-gp) efflux function with greater activity and less side effect, the combined effect of pair CJZ3 and verapamil (Ver) was evaluated isobolographically in numerous fixed-ratio combinations of 1:1, 1:2, 1:4, 1:8, 1:10 in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells and in rat brain microvessel endothelial cells (RBMEC). The results displayed that mixtures of both drugs at the fixed-ratios of 1:2, 1:4, 1:8, 1:10 exerted synergistic interactions, indicating that when the two reversers that bind P-gp on separated sites were combined, each can contribute to the overall interaction with P-gp, leading to the greater effect than that given by either agent alone. Drug Dev Res 72:305-309, 2011. (C) 2010 Wiley-Liss, Inc.
What problem does this paper attempt to address?